These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 13255446)

  • 21. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
    Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
    Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunobiology of T cell therapies for leukemias.
    Shlomchik WD; Emerson SG
    Acta Haematol; 1996; 96(4):189-213. PubMed ID: 8922486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DRUGS used in the palliation of leukemia.
    Am J Pharm Sci Support Public Health; 1956 Jul; 128(7):235-41. PubMed ID: 13354732
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.
    Styczyński J; Wysocki M; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk A; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Neoplasma; 2002; 49(3):178-83. PubMed ID: 12098004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs.
    Fox JM; Moynihan JR; Mott BT; Mazzone JR; Anders NM; Brown PA; Rudek MA; Liu JO; Arav-Boger R; Posner GH; Civin CI; Chen X
    Oncotarget; 2016 Feb; 7(6):7268-79. PubMed ID: 26771236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiles of activation, differentiation-markers, or β-integrins on T cells contribute to predict T cells' antileukemic responses after stimulation with leukemia-derived dendritic cells.
    Vogt V; Schick J; Ansprenger C; Braeu M; Kroell T; Kraemer D; Köhne CH; Hausmann A; Buhmann R; Tischer J; Schmetzer H
    J Immunother; 2014; 37(6):331-47. PubMed ID: 24911794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
    Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The graft versus leukemia effect: possible mechanisms and clinical significance to the biologic therapy of leukemia.
    Sosman JA; Sondel PM
    Bone Marrow Transplant; 1991; 7 Suppl 1():33-7. PubMed ID: 2043883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On the mode of action of heterologous antileukemic sera. Growth of syngeneically transplanted leukemia cells on serum treated neonatally thymectomized mice (author's transl)].
    Milleck J; Petro J; Madri M; Broen B; Eckert R
    Arch Geschwulstforsch; 1975; 45(6):541-4. PubMed ID: 1225257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents.
    Barrett AJ; Savani BN
    Leukemia; 2006 Oct; 20(10):1661-72. PubMed ID: 16871277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antigenic properties of certain drugs used in therapy of leukemia].
    KHAROVA EI; RAUSHENBAKH MO
    Probl Gematol Pereliv Krovi; 1959 May; 4(5):29-35. PubMed ID: 13658102
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mode of action of chemotherapy of leukemia; the morphologic modifications induced by the antimitotics on normal and leukemic hemopoiesis; their biologic and clinical value].
    INTROZZI P
    Rev Hematol; 1955; 10(2):463-72. PubMed ID: 13255443
    [No Abstract]   [Full Text] [Related]  

  • 34. Carbamates in the chemotherapy of leukemia; the relationship between chemical structure and anti-leukemic action of a series of urethan derivatives.
    SKIPPER HE; BRYAN CE
    J Natl Cancer Inst; 1949; 9(5-6):391-7. PubMed ID: 18153814
    [No Abstract]   [Full Text] [Related]  

  • 35. Antileukemic activity of phenylalanine methyl ester (PME): a lysosomotropic peptide methyl ester.
    Rosenfeld CS
    Stem Cells; 1994 Mar; 12(2):198-204. PubMed ID: 8199562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of leukemia.
    HIBINO S
    Gan; 1956 Dec; 47(3-4):454-60. PubMed ID: 13415081
    [No Abstract]   [Full Text] [Related]  

  • 37. An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation.
    Huang X; Guo N; Ren H; Zhang Y; Gao Z; Lu D
    Chin Med J (Engl); 2003 May; 116(5):736-41. PubMed ID: 12875692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
    Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells.
    Troeger A; Meisel R; Moritz T; Dilloo D
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S59-64. PubMed ID: 15812533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical aspects and therapeutic perspectives of acute and chronic leukemias.
    Hiddemann W; Griesinger F
    Curr Opin Oncol; 1993 Jan; 5(1):13-25. PubMed ID: 8427885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.